NJ-based Clinical Investigational Site Profile: Amici Clinical Research Gears up for COVID-19 Vaccine Trial
Raritan, New Jersey-based Amici Clinical Research is gearing up for a busy summer as it seeks to conduct up to […]
On the Front Lines During the First Wave of COVID-19 Pandemic: Hackensack Meridian Health Publishing
New Jersey’s largest network of healthcare providers, Hackensack Meridian Health (HMH) operates in the hub of the COVID-19 pandemic during March […]
New Jersey-based Hackensack Meridian Health a Force for COVID-19 Research Treating 1,000 Clinical Trial Patients
Hackensack Meridian Health, a network of New Jersey-based health providers, reached a major milestone in serving as a COVID-19 clinical investigational […]
Rutgers Cancer Institute of New Jersey Seeks Major Expansion to Meet Demands & Compete for NCI Designation
Rutgers Cancer Institute of New Jersey unveiled plans for a proposed 12-story cancer treatment and research center with a $750 […]
New Jersey’s John Theurer Cancer Center at Hackensack Hires Five New Physicians
The John Theurer Cancer Center at Hackensack University Cancer Center in New Jersey as added five new physicians. TrialSite News shares […]
Atlantic Health System Clinical Investigator Discusses Pancreatic Cancer Trial Results with NJ Women’s Group
Dr. Angela Alistar, medical director of GI medical oncology at Atlantic Health System’s Morristown Medical Center recently spoke at the […]
Atlantic Health Cancer Consortium Joins NCI-Funded NCORP for Clinical Research as a Care Option
Atlantic Health System has been awarded a National Community Oncology Research Program (NCORP) designated grant from the National Cancer Institute […]
RWJBarnabas Health & Rutgers Cancer Institute Announce $750M Cancer Pavilion
Tapinto Piscataway reports that RWJBarnabas Health and Rutgers Cancer Institute, in partnership with the New Brunswick Development Corporation, announced the […]
